VPH 2022 Workshops

The following workshops will take place on the pre-conference day, September 6, 2022.
Please note that subscription for workshops is required as the capacity might be limited.
There is no additional cost for workshops subscription.
The workshops registration platform is reserved exclusively to participants already registered for VPH 2022.
Update: The maximum capacity of the workshop number 3 has already been reached.

Workshop 1: Using CompuCell3D as a Platform to Construct Multi-Scale Multicellular Agent-Based Virtual-Tissue Simulations of Development and Disease

September 6th, 10:00 – 13:00

Multi-scale, Multicellular Agent-Based Virtual-Tissue models built using modeling frameworks like CompuCell3D are versatile tools for exploring the complex interactions between intracellular signaling and gene-regulatory networks, inter-cellular signaling through contact and diffusible signals, and force generation, cell migration and shape change. Among other applications the open-source modeling environment CompuCell3D has been used successfully to build models of vascular tumor growth and therapy, embryonic development, liver and developmental toxicology, lung infection, immune response and anti-viral therapies. This workshop will explore how CompuCell3D can simplify the construction of complex, extensible and reusable Virtual Tissue models. Members of the audience will build and explore models by downloading the software from (www.compucell3d.org) or run it on-line at (https://nanohub.org/resources/cc3dbase4x; free with required registration).

Prof. James A. Glazier, Biocomplexity Institute and Department of Intelligent Systems Engineering, Indiana University, Bloomington, USA


Workshop 2: SIMCARDIOTEST OPEN SOURCE SOFTWARE – DEMO on OASIS: Computational fluid dynamics solver & SOFA: Simulation Open Framework Architecture

September 6th, 14:00 – 16:00

SimCardioTest is a collaborative project between 10 organizations from 6 European countries and United States funded by the European Commission (EU H2020). The aim of the project is to provide new insight into designing predictive tools in cardiac pathologies and to accelerate the uptake of computer simulations for testing medicines and medical devices.

The aim of the workshop is  hands on/demonstration of the open source OASIS and SOFA software.

OASIS demo: Simulating Fluid-Structure Interaction in the Left Atrial Appendage, Kei Yamamoto, Simula
SOFA demo: Simulation Open Framework Architecture, Camille Krewcun, Inria
SimCardioTest short introduction: Michele Barbier, Inria

Workshop 3: Public and patient outreach and engagement for in silico medicine

September 6th, 14:00 – 17:00

The importance of involving multiple stakeholders, and in particular patients and healthcare professionals, when innovative technologies are developed is recognised as best practice in health care research. Public (including healthcare professionals) and patient engagement (PE) is also at the heart of the European strategy for research and innovation and has become an essential requirement to receive funding. Nevertheless, very few prior initiatives or literature exist on that matter when it comes to in silico medicine and few documents exist to guide in silico experts in that endeavor. What is the role of PE for in silico research? How can we apply it while making the most of it? What are the best practices? How to effectively communicate about in silico medicine to the public? The workshop will address those questions by gathering actors and experts from the field. General PE role, principles and best practices will also be discussed from a patient perspective, with the participation of EUPATI (European Patients’ Academy on Therapeutic Innovation). Since public and patient engagement goes hand in hand with outreach activities and good communication skills to large audiences, we propose a hands-on session on ‘communicating your in silico research to a general audience’ that will be held and moderated by a professional.

Co-organized by the VPH institute, the Avicenna-Alliance Public-Patient Involvement (PPI) task force